Cefotetan-induced hemolytic anemia causing severe hypophosphatemia.
Phosphorus is a major component of proteins, phospholipids, and nucleotides. The increased uptake of phosphorus by cells during erythropoiesis can result in severe hypophosphatemia. A case of severe hypophosphatemia due to accelerated erythropoiesis in response to Cefotetan-induced hemolytic anemia is described. The hypophosphatemia seen during hemolysis may be the result, rather than the cause, of the hemolysis.
Mohammed
S
S
Division of Gastroenterology, Brown University, School of Medicine, Providence, Rhode Island.
Knoll
S
S
van Amburg
A
A
Mennes
P A
PA
D000743:Anemia, Hemolytic / Q000150:complications* / Q000209:etiology* / Q000503:physiopathology; D015313:Cefotetan / Q000009:adverse effects*; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology*; D008875:Middle Aged
D015313:Cefotetan